A detailed history of Alpha Family Trust transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Alpha Family Trust holds 18,760 shares of BMY stock, worth $1.09 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
18,760
Previous 9,330 101.07%
Holding current value
$1.09 Million
Previous $387,000 150.65%
% of portfolio
0.55%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$39.66 - $51.75 $373,993 - $488,002
9,430 Added 101.07%
18,760 $970,000
Q2 2024

Aug 09, 2024

BUY
$40.25 - $52.99 $375,532 - $494,396
9,330 New
9,330 $387,000
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $344,692 - $411,313
7,110 New
7,110 $364,000
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $296,518 - $351,119
4,330 New
4,330 $311,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alpha Family Trust Portfolio

Follow Alpha Family Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Family Trust, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Family Trust with notifications on news.